Akari Therapeutics Plc - American Depositary Shares - balanço patrimonial (NASDAQ:AKTX) | MetaTrader

Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas

Total assets 14.6 M11.65 M13.83 M4.36 M50.56 M47.89 M Total liabilities 5.22 M6.09 M12.04 M4.58 M28.33 M19.56 M Total equity 9.38 M5.55 M1.79 M-229 K22.23 M28.33 M Total liabilities & shareholders' equities 14.6 M11.65 M13.83 M4.36 M50.56 M47.89 M Total debt ————1.36 M754 K Net debt ————-1.24 M754 K

Notícias

Akari Therapeutics firma parceria com WuXi XDC para desenvolvimento de ADC

Upcoming Stock Splits This Week (March 30 to April 2) – Stay Invested - TipRanks.com

Akari Therapeutics ajusta proporção de ADS para cumprir regras da Nasdaq

Akari Therapeutics completa um ano sob o comando do CEO Gaslightwala

Akari Therapeutics marks one year under CEO Gaslightwala

Akari Therapeutics adiciona especialista em splicing de RNA ao conselho consultivo

Akari Therapeutics adds RNA splicing expert to advisory board

Why Vanda Pharmaceuticals Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Antelope Ent Hldgs (NASDAQ:AEHL), Aimei Health Technology (NASDAQ:AFJK)

Akari Therapeutics avança programa de oncologia ADC com nova carga útil

Akari Therapeutics advances ADC oncology program with novel payload

Akari inicia fabricação GMP de programa principal de ADC com WuXi XDC

Akari begins GMP manufacturing of lead ADC program with WuXi XDC